2.94

2.44% 0.07

Hcw Biologics Inc (HCWB)

Overview News Price History Financials Discussions Forecast

Hcw Biologics Inc stock is traded at $2.94, with a volume of 35,624. It is up +2.44% in the last 24 hours and down -18.33% over the past month. HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Previous Close:

$2.87

Open:

$2.81

24h Volume:

35,624

Relative Volume:

0.05

Market Cap:

$5.40M

Revenue:

$6.59M

Net Income/Loss:

$-18.12M

P/E Ratio:

-0.3108

EPS:

-9.4605

Net Cash Flow:

$-11.45M

1W Performance:

-14.29%

1M Performance:

-18.33%

6M Performance:

-25.38%

1Y Performance:

-89.42%

1-Day Range:

$2.80

$2.97

1-Week Range:

$2.7001

$3.81

52-Week Range:

$1.50

$36.65

Hcw Biologics Inc Stock (HCWB) Company Profile

Name

Hcw Biologics Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

954-842-2024

Address

2929 N COMMERCE PKWY, MIRAMAR

Employee

Twitter

Next Earnings Date

2026-08-17

Latest SEC Filings

HCWB's Discussions on Twitter

Compare HCWB vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCWB Hcw Biologics Inc	2.94	3.89M	6.59M	-18.12M	-11.45M	-9.4605
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Hcw Biologics Inc Stock (HCWB) Latest News

Aug 20, 2026

HCW Biologics (NASDAQ: HCWB) registers PIPE, warrant shares - Stock Titan

Aug 20, 2026

HCW Biologics regains Nasdaq bid price compliance - scanx.trade

Aug 20, 2026

Aug 19, 2026

581,047 Common Stock of HCW Biologics Inc. are subject to a Lock-Up Agreement Ending on 20-AUG-2026. - marketscreener.com

Aug 19, 2026

Aug 18, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Aug 18, 2026

Aug 17, 2026

HCWB Q1 2026 Earnings: EPS of $2.22 Smashes Consensus by 182.44% Despite No RevenueHigh Estimate Range - vinanet.vn

Aug 17, 2026

Aug 15, 2026

HCW Biologics (HCWB) Slides 8.4% to $2.68 as Key Support Level Comes into FocusDividend Arbitrage - Vinanet

Aug 15, 2026

Aug 14, 2026

HCW Biologics Q2 net loss widens to $5.2M despite revenue surge - scanx.trade

Aug 14, 2026

Form 8K HCW Biologics Inc For: 14 August By Investing.com - Investing.com Nigeria

Aug 14, 2026

HCW Biologics Inc. Q2 2026: Revenue $135.6K, EPS $(11.58) — 10-Q Summary - TradingView

Aug 14, 2026

HCW Biologics (HCWB) posts higher 2026 revenue but flags going-concern risk - Stock Titan

Aug 14, 2026

HCW Biologics Reports Second Quarter 2026 Financial Results and Updates HCW9302 Alopecia Areata Program, HCW11-018b Development and Financing Activities - Quiver Quantitative

Aug 14, 2026

HCW Biologics trial: 3 alopecia patients cut SALT scores 25%+ - Stock Titan

Aug 14, 2026

Aug 11, 2026

HCWB Q1 2026 Earnings: Surprise EPS of $2.22 vs. Expected Loss, Yet Shares Slip 3.06%Consensus Miss Rate - Vinanet

Aug 11, 2026

Aug 07, 2026